ClearPoint Neuro (CLPT) Competitors $11.20 -0.15 (-1.32%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$11.16 -0.04 (-0.36%) As of 09/19/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLPT vs. ESTA, MDXG, PLSE, INMD, IRMD, BBNX, EMBC, KMTS, TNDM, and AXGNShould you be buying ClearPoint Neuro stock or one of its competitors? The main competitors of ClearPoint Neuro include Establishment Labs (ESTA), MiMedx Group (MDXG), Pulse Biosciences (PLSE), InMode (INMD), iRadimed (IRMD), Beta Bionics (BBNX), Embecta (EMBC), Kestra Medical Technologies (KMTS), Tandem Diabetes Care (TNDM), and AxoGen (AXGN). These companies are all part of the "medical equipment" industry. ClearPoint Neuro vs. Its Competitors Establishment Labs MiMedx Group Pulse Biosciences InMode iRadimed Beta Bionics Embecta Kestra Medical Technologies Tandem Diabetes Care AxoGen Establishment Labs (NASDAQ:ESTA) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership. Which has more volatility and risk, ESTA or CLPT? Establishment Labs has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500. Comparatively, ClearPoint Neuro has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Does the media refer more to ESTA or CLPT? In the previous week, Establishment Labs had 2 more articles in the media than ClearPoint Neuro. MarketBeat recorded 4 mentions for Establishment Labs and 2 mentions for ClearPoint Neuro. Establishment Labs' average media sentiment score of 1.04 beat ClearPoint Neuro's score of 0.00 indicating that Establishment Labs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ClearPoint Neuro 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable valuation and earnings, ESTA or CLPT? ClearPoint Neuro has lower revenue, but higher earnings than Establishment Labs. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEstablishment Labs$166.02M6.89-$84.60M-$3.05-12.94ClearPoint Neuro$31.39M10.14-$18.91M-$0.81-13.83 Do analysts recommend ESTA or CLPT? Establishment Labs presently has a consensus target price of $56.50, suggesting a potential upside of 43.18%. ClearPoint Neuro has a consensus target price of $19.67, suggesting a potential upside of 75.60%. Given ClearPoint Neuro's stronger consensus rating and higher possible upside, analysts plainly believe ClearPoint Neuro is more favorable than Establishment Labs.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Establishment Labs 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83ClearPoint Neuro 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is ESTA or CLPT more profitable? Establishment Labs has a net margin of -49.89% compared to ClearPoint Neuro's net margin of -66.15%. ClearPoint Neuro's return on equity of -94.44% beat Establishment Labs' return on equity.Company Net Margins Return on Equity Return on Assets Establishment Labs-49.89% -224.34% -25.53% ClearPoint Neuro -66.15%-94.44%-51.58% Do insiders & institutionals hold more shares of ESTA or CLPT? 72.9% of Establishment Labs shares are owned by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are owned by institutional investors. 11.1% of Establishment Labs shares are owned by insiders. Comparatively, 7.0% of ClearPoint Neuro shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryEstablishment Labs beats ClearPoint Neuro on 9 of the 16 factors compared between the two stocks. Get ClearPoint Neuro News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CLPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLPT vs. The Competition Export to ExcelMetricClearPoint NeuroMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$322.65M$6.82B$5.79B$10.40BDividend YieldN/A1.20%5.63%4.60%P/E Ratio-13.8326.7876.4826.75Price / Sales10.14197.91531.72124.23Price / CashN/A22.0337.9261.55Price / Book12.174.9813.726.40Net Income-$18.91M$178.07M$3.29B$271.62M7 Day Performance6.77%5.36%2.65%3.46%1 Month Performance8.00%10.93%6.01%9.87%1 Year Performance-9.68%17.52%80.02%28.45% ClearPoint Neuro Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLPTClearPoint Neuro1.5236 of 5 stars$11.20-1.3%$19.67+75.6%-7.7%$322.65M$31.39M-13.83110High Trading VolumeESTAEstablishment Labs2.2573 of 5 stars$38.24-2.0%$56.50+47.8%-10.2%$1.13B$166.02M-12.541,018Positive NewsMDXGMiMedx Group3.4714 of 5 stars$7.17+0.4%$12.00+67.4%+12.7%$1.06B$348.88M34.14870Positive NewsPLSEPulse Biosciences4.2299 of 5 stars$15.04-0.5%$22.00+46.3%-6.0%$1.02B$700K-14.32140Positive NewsInsider TradeINMDInMode2.971 of 5 stars$15.28+2.0%$18.04+18.1%-17.1%$946.87M$401.56M6.19480Positive NewsIRMDiRadimed4.8134 of 5 stars$71.85-0.2%$72.00+0.2%+43.2%$915.36M$73.24M44.35110News CoverageInsider TradeShort Interest ↓BBNXBeta Bionics1.0045 of 5 stars$23.13+14.5%$22.56-2.5%N/A$878.10M$65.12M0.00294High Trading VolumeEMBCEmbecta4.4591 of 5 stars$14.65-2.1%$19.00+29.7%-8.7%$874.94M$1.12B10.242,100Positive NewsKMTSKestra Medical Technologies0.866 of 5 stars$17.86+5.1%$27.33+53.0%N/A$872.93M$59.81M0.00300TNDMTandem Diabetes Care4.2623 of 5 stars$12.50-0.6%$22.44+79.5%-71.7%$850.02M$940.20M-4.052,650Positive NewsAXGNAxoGen2.8592 of 5 stars$16.04+0.4%$26.00+62.1%+17.2%$735.28M$187.34M-160.38450Positive News Related Companies and Tools Related Companies Establishment Labs Competitors MiMedx Group Competitors Pulse Biosciences Competitors InMode Competitors iRadimed Competitors Beta Bionics Competitors Embecta Competitors Kestra Medical Technologies Competitors Tandem Diabetes Care Competitors AxoGen Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLPT) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ClearPoint Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ClearPoint Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
